Agios Pharma (AGIO) PT Raised to $86 at Needham & Company; 'Continued Execution'
Tweet Send to a Friend
Needham & Company raised its price target on Agios Pharma (NASDAQ: AGIO) to $86.00 (from $72.00) while maintaining a Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
